News

ViiV Healthcare has signed a global collaboration and license agreement with Halozyme Therapeutics to develop “ultra-long-acting” medicines for HIV. The deal gives exclusive access to Halozyme’s ENHANZE drug

The European Commission has purchased an additional 150 million Moderna’s Covid-19 vaccine doses, bringing its confirmed order commitment to 460 million doses. The deal also includes an option

Arrowhead Pharmaceuticals has signed a global collaboration and license agreement with Horizon Therapeutics for the development of RNA interference (RNAi) therapeutic, ARO-XDH. ARO-XDH is a discovery-stage investigational RNAi

Court of First Instance of Brussels has ordered AstraZeneca to deliver 50 million doses of its Covid-19 vaccine to Europe by 27 September this year. The court decided to

Established in 1998, Aldevron is headquartered in Fargo, North Dakota, US. The company produces plasmid DNA, mRNA and recombinant proteins used in vaccines, gene and cell therapy, gene editing

An investigational radioligand therapy, 177Lu-PSMA-617 is intended for precision cancer treatment. It is a combination of a targeting compound (ligand) and a therapeutic radioisotope. On administration into the

The approval is for cases where surgical intervention is a clinical indication, also known as deep partial thickness burns. StrataGraft is made of allogeneic cultured keratinocytes and dermal

TIGIT, a part of the CD226 checkpoint axis, has shown potential as a promising target for the next generation of immuno-oncology therapies based on preclinical data and a

Biotechnology company Moderna has secured approval from the European Medicines Agency’s (EMA) committee for human medicines (CHMP) for a new Covid-19 vaccine manufacturing site in Monts, France. Addition